A First-In-Human Study of Single and Multiple Ascending Doses of Oral SUL-238 in Healthy Subjects

NCT06277492 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Single ascending doses SUL-238
DRUG: Single dose Placebo
DRUG: Single dose SUL-238
DRUG: Multiple ascending doses SUL-238
DRUG: Multiple doses Placebo
DRUG: 2000 mg SUL-238 single dose for pharmacokinetics (food effect)
DRUG: Single dose placebo (food effect)

Sponsor

GEN İlaç ve Sağlık Ürünleri A.Ş.

Collaborators

[object Object]